Related Experiment Video
Updated: Sep 25, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
A Controversial Relationship Between Crohn's Disease and Hidradenitis Suppurativa: A Case Series and Literature
Faith Buchanan1, Saad Saleem2, Mohd Amer Alsamman3
1Internal Medicine, MedStar Washington Hospital Center, Washington, D.C., USA.
Insights
This case series explores the connection between Crohn's disease (CD) and hidradenitis suppurativa (HS). It highlights treatment approaches and the potential for biologic agents to paradoxically worsen HS in CD patients.
Area of Science:
- Gastroenterology
- Dermatology
- Immunology
Background:
- Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) with significant extraintestinal manifestations.
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition frequently associated with CD.
Observation:
- This case series details three patients with co-occurring CD and HS, examining disease presentation, severity, and management.
- Two patients developed HS after CD diagnosis; one presented with HS first, followed by gastrointestinal symptoms.
- All three patients required surgical intervention for HS.
Findings:
- Treatment varied, including biologic agents (BA), cytotoxic agents, and management without biologics.
- One patient experienced treatment failure with one BA but responded to another.
- A potential paradoxical side effect of BA in inducing or exacerbating HS was observed in one patient.
Implications:
- The relationship between CD and HS warrants further investigation, potentially through prospective studies.
- Evaluating the causal link between BAs (adalimumab, infliximab) and HS is crucial for managing both conditions.
- Increased physician awareness of CD-HS comorbidity is essential for improving patient quality of life.
Abstract:
Crohn's disease (CD) is an inflammatory bowel disease (IBD) with major extraintestinal manifestations. Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that has previously been described to have a strong association with CD. Though the pathophysiology remains uncertain, this case series highlights the different aspects of disease presentation, similarities, severity, current treatment modalities, and the relational conflict between HS as a paradoxical side effect of biologic agents (BA) that is not well established. We identified a total of three patients with CD and HS and described their clinical presentation and management. A systematic search of the literature with PubMed and Ovid MEDLINE was done in 2021. Two patients were initially diagnosed with CD prior to developing skin manifestations. The third patient was diagnosed with HS first, then was found to have gastrointestinal symptoms. All patients had HS requiring surgical intervention. One patient failed a biological agent but responded to another. The second patient was treated with cytotoxic agents with acceptable results. The third patient was managed without the use of biologics. One of three patients' clinical courses may suggest a paradoxical side effect of BA. The relationship between CD and HS is based on several case reports. A prospective study will help establish the relationship as well as shed light on the treatment of both conditions simultaneously. In addition, further evaluation of the causal relationship between BA, specifically adalimumab and infliximab as treatment for CD and HS are warranted to effectively manage Crohn's disease, evaluate paradoxical HS, and improve outcomes of both HS and CD. CD and HS impact a patient's quality of life and physicians should therefore have a high degree of awareness upon diagnosis.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids